scispace - formally typeset
S

Sheela Hota-Mitchell

Researcher at University of Western Ontario

Publications -  5
Citations -  560

Sheela Hota-Mitchell is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Myxoma virus & Genome. The author has an hindex of 5, co-authored 5 publications receiving 548 citations. Previous affiliations of Sheela Hota-Mitchell include Robarts Research Institute.

Papers
More filters
Journal ArticleDOI

The complete DNA sequence of myxoma virus.

TL;DR: This work affirms the existence of a conserved complement of poxvirus-specific core genes and expands the growing repertoire of virus genes that confer the unique capacity of each poxVirus family member to counter the immune responses of the infected host.
Journal ArticleDOI

Immunomodulation by viruses: the myxoma virus story

TL;DR: Two distinct viral strategies carried out by viral proteins with which myxoma virus subverts the host immune response are described, which can provide insights into virus‐host interactions and also provide new insights into the complex immune system.
Journal ArticleDOI

Immunomodulatory proteins of myxoma virus.

TL;DR: Some of the new open reading frames discovered during the sequencing of the myxoma virus DNA genome contain intriguing similarities to known cellular and viral proteins in the public domain for which immunomodulatory functions have been assigned.
Journal ArticleDOI

Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain.

TL;DR: Evidence is presented for the protective capacity of several schistosomal antigen preparations, including a calcium binding protein of the APM, S. mansoni calpain, and data indicate that Sm-p80 may be a useful vaccine antigen for the reduction of the morbidity associated with S.mansoni infections of mammalian hosts.
Journal ArticleDOI

Recombinant vaccinia viruses and gene gun vectors expressing the large subunit of Schistosoma mansoni calpain used in a murine immunization-challenge model.

TL;DR: Preliminary in vivo studies demonstrate the potential for further study of the protection afforded by gene gun-delivered WRG-full5' mut p80 into subsequently-challenged mice and may pave the way to effective vaccination of humans using WRG DNA vectors expressing a schistosomal calcium-activated neutral protease.